Search

349 results for “drugs”

• Research LetterOpen Access

  Therapeutic drug monitoring of modified release once daily tacrolimus in de novo renal transplant with conversion to a twice daily generic in the stable period

  Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V

  Vol. 6 · Issue 3 · pp. 154–156

  https://doi.org/10.4103/0976-500X.162021
  Full text ↗PDF

• Research PaperOpen Access

  Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reports

  Ilma Bertulyte, Sofie Schwan, Pär Hallberg

  Vol. 5 · Issue 2 · pp. 100–138

  https://doi.org/10.4103/0976-500X.130051
  Full text ↗PDF

• Research LetterOpen Access

  Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital

  Raghava Sharma, Adithi Kellarai

  Vol. 5 · Issue 4 · pp. 248–250

  https://doi.org/10.4103/0976-500X.142436
  Full text ↗PDF

• CorrespondenceOpen Access

  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme

  Dick B. S. Brashier, Sushil Sharma

  Vol. 3 · Issue 1 · pp. 74–75

  https://doi.org/10.4103/0976-500X.92501
  Full text ↗PDF

• Research LettersOpen Access

  Physicians’ and patients’ opinions on the use of generic drugs

  Antoni Sicras-Mainar, Ruth Navarro-Artieda

  Vol. 3 · Issue 3 · pp. 268–270

  https://doi.org/10.4103/0976-500X.99438
  Full text ↗PDF

• Mini ReviewOpen Access

  Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form

  Anshi Singh, Parloop Bhatt

  Vol. 3 · Issue 3 · pp. 228–229

  https://doi.org/10.4103/0976-500X.99417
  Full text ↗PDF

• Research ArticleOpen Access

  Critical Evaluation of Drug Promotional Literature Using WHO Ethical Criteria and Perception of Clinicians at a Tertiary Care Hospital

  Amanjot Kaur, Shweta Singla, Mandeep Kaur, Jasninder Singh

  Vol. 14 · Issue 1 · pp. 41–46

  https://doi.org/10.1177/0976500X231164812
  Full text ↗PDF

• Research ArticleOpen Access

  Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study

  Velammal Petchiappan, Elsa Mathew, Josna Jose, Mohamed Fardan, Yoganathan Chidambaram, Saravanan Thangavelu

  Vol. 14 · Issue 1 · pp. 72–78

  https://doi.org/10.1177/0976500X231175219
  Full text ↗PDF

• Research ArticleOpen Access

  Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis

  Smrati Tiwari, Zahaan Vakil

  Vol. 13 · Issue 2 · pp. 197–202

  https://doi.org/10.1177/0976500X221105759
  Full text ↗PDF

• Research PaperOpen Access

  Antianginal Efficacy and Tolerability of Ranolazine as an Add‑on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open‑Label Study

  Anant Mahaveer Khot, H. V. Anuradha, V. S. Prakash, M. C. Shivamurathy

  Vol. 8 · Issue 1 · pp. 21–27

  https://doi.org/10.4103/jpp.JPP_168_16
  Full text ↗PDF

• Research PaperOpen Access

  Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia

  Charanraj Goud Alladi, Anbarasan Mohan, Deepak Gopal Shewade, Ravi Philip Rajkumar, Surendiran Adithan, Karthick Subramanian

  Vol. 8 · Issue 1 · pp. 28–32

  https://doi.org/10.4103/jpp.JPP_197_16
  Full text ↗PDF

• Case ReportOpen Access

  Fixed drug eruption due to levocetirizine

  Ratinder Jhaj, Dinesh Prasad Asati, Deepa Chaudhary

  Vol. 7 · Issue 2 · pp. 109–11

  https://doi.org/10.4103/0976-500X.184778
  Full text ↗PDF

• Review ArticleOpen Access

  Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon

  Vishal Sehgal, Sukhminder Jit Singh Bajwa, Rinku Sehgal, John A Consalvo

  Vol. 5 · Issue 4 · pp. 227–231

  https://doi.org/10.4103/0976-500X.142428
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Lorcaserin: A novel antiobesity drug

  Dick B. S. Brashier, A. K. Sharma, Navdeep Dahiya, S. K. Singh, Anjan Khadka

  Vol. 5 · Issue 2 · pp. 175–178

  https://doi.org/10.4103/0976-500X.130158
  Full text ↗PDF

• Research LetterOpen Access

  Pediatric dosing errors due to variable drug formulations

  Sumit Mehndiratta

  Vol. 5 · Issue 4 · pp. 254–255

  https://doi.org/10.4103/0976-500X.142444
  Full text ↗PDF

• WebwiseOpen Access

  The portal for rare diseases and orphan drugs

  Jatinder Singh

  Vol. 4 · Issue 2 · pp. 168–9

  Full text ↗PDF

• Research PaperOpen Access

  Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital

  Maulik S. Doshi, Prakruti P. Patel, Samidh P. Shah, Ram K Dikshit

  Vol. 3 · Issue 4 · pp. 308–313

  https://doi.org/10.4103/0976-500X.103687
  Full text ↗PDF

• Research PaperOpen Access

  Patient factors impacting antiretroviral drug adherence in a Nigerian tertiary hospital

  Kakjing D. Falang, P. Akubaka, N. S. Jimam

  Vol. 3 · Issue 2 · pp. 138–142

  https://doi.org/10.4103/0976-500X.95511
  Full text ↗PDF

• Research LettersOpen Access

  Reporting of adverse drug reactions in clinical trials published in Indian Medical/Dental journals

  Purav Mody, Tamoghona Biswas, Jaykaran Charan, Deval Parikh

  Vol. 3 · Issue 4 · pp. 325–326

  https://doi.org/10.4103/0976-500X.103690
  Full text ↗PDF

• Review ArticleOpen Access

  A Systematic Review and Meta-analysis of Selective Cyclooxygenase-2 Inhibitors and Non-selective Non-steroidal Anti-inflammatory Drugs for Acute Gout

  Swathy Govindaswamy, Kavya Ponnusamy, Indhumathi S., Vineeth Anil, Jayalakshmi Venugopal, Dhivya P. Sundaram

  Vol. 15 · Issue 2 · pp. 122–132

  https://doi.org/10.1177/0976500X241240629
  Full text ↗PDF